Karl Pawlik

Karl Pawlik is an accomplished finance professional with extensive experience in executive roles across various companies in the healthcare and technology sectors. Currently serving as Consulting CFO at Early Growth, an Escalon Company, Karl manages financial, accounting, HR, and insurance functions for over 150 clients in the life sciences sector. As CFO of Spark Biomedical Inc, Karl plays a key role in financial strategy. Previous positions include Consulting CFO at Early Growth Financial Services, where Karl supported venture-backed firms, and senior leadership roles at Neural Analytics and MIVI Neuroscience, driving capital raises and market strategy for medical devices. Earlier career highlights include significant contributions at St. Jude Medical and Applied Materials, where Karl led financial analysis and market research initiatives. Karl holds an MBA from California State University, Northridge and a Bachelor of Science in Business Administration from the University of Arizona, specializing in Finance and Accounting.